While citrus aurantium may have fewer side effects and be easier to obtain than prescription diet pills, I think the risk, cost and lack of clear benefit of supplements containing this compound do not ...

Wall Street investment firm Jefferies Financial Group (JEF) is forecasting more than $10 billion in annual sales from Eli Lilly’s (LLY) new weight-loss pill that’s expected to hit the market in 2026.

Eli Lilly’s experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said.